chrX-153506075-C-T
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001711.6(BGN):c.564C>T(p.Ile188Ile) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0172 in 1,207,610 control chromosomes in the GnomAD database, including 286 homozygotes. There are 6,479 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001711.6 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BGN | NM_001711.6 | c.564C>T | p.Ile188Ile | splice_region_variant, synonymous_variant | 4/8 | ENST00000331595.9 | NP_001702.1 | |
BGN | XM_017029724.3 | c.564C>T | p.Ile188Ile | splice_region_variant, synonymous_variant | 3/7 | XP_016885213.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BGN | ENST00000331595.9 | c.564C>T | p.Ile188Ile | splice_region_variant, synonymous_variant | 4/8 | 1 | NM_001711.6 | ENSP00000327336.4 |
Frequencies
GnomAD3 genomes AF: 0.0339 AC: 3809AN: 112234Hom.: 98 Cov.: 23 AF XY: 0.0311 AC XY: 1070AN XY: 34400
GnomAD3 exomes AF: 0.0235 AC: 4272AN: 181513Hom.: 101 AF XY: 0.0200 AC XY: 1328AN XY: 66291
GnomAD4 exome AF: 0.0155 AC: 16939AN: 1095322Hom.: 187 Cov.: 32 AF XY: 0.0150 AC XY: 5404AN XY: 360902
GnomAD4 genome AF: 0.0340 AC: 3818AN: 112288Hom.: 99 Cov.: 23 AF XY: 0.0312 AC XY: 1075AN XY: 34464
ClinVar
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 16, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 21, 2023 | - - |
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 30, 2018 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at